Exact Mass: 606.2663
Exact Mass Matches: 606.2663
Found 142 metabolites which its exact mass value is equals to given mass value 606.2663
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cepharanthine
Cepharanthine is a bisbenzylisoquinoline alkaloid from tubers of Stephania; stimulates recovery of immunologic function in lymphatic system after administration of antineoplastic agents or x-irradiation. It is a member of isoquinolines and a bisbenzylisoquinoline alkaloid. Cepharanthine is a natural product found in Stephania sinica, Stephania cephalantha, and other organisms with data available. A bisbenzylisoquinoline alkaloid from tubers of Stephania; stimulates recovery of immunologic function in lymphatic system after administration of antineoplastic agents or x-irradiation. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D020011 - Protective Agents > D011837 - Radiation-Protective Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids Cepharanthine is a natural product that can be isolated from the plant Stephania?cephalantha?Hayata. Cepharanthine has anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) activities. Cepharanthine has good effective in suppressing viral proliferation (half maximal (50\\%) inhibitory concentration (IC50) and 90\\% inhibitory concentration (IC90) values of 1.90 and 4.46?μM[1]. Cepharanthine can also effectively reverses P-gp-mediated multidrug resistance in K562 cells and increase enhances the sensitivity of anticancer agents in xenograft mice model[2][3]. Cepharanthine shows inhibitory effects of human liver cytochrome P450 enzymes CYP3A4, CYP2E1 and CYP2C9. Cepharanthine has antitumor, anti-inflammatory and antinociceptive effects[4][5][6][7][8]. Cepharanthine is a natural product that can be isolated from the plant Stephania?cephalantha?Hayata. Cepharanthine has anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) activities. Cepharanthine has good effective in suppressing viral proliferation (half maximal (50\%) inhibitory concentration (IC50) and 90\% inhibitory concentration (IC90) values of 1.90 and 4.46?μM[1]. Cepharanthine can also effectively reverses P-gp-mediated multidrug resistance in K562 cells and increase enhances the sensitivity of anticancer agents in xenograft mice model[2][3]. Cepharanthine shows inhibitory effects of human liver cytochrome P450 enzymes CYP3A4, CYP2E1 and CYP2C9. Cepharanthine has antitumor, anti-inflammatory and antinociceptive effects[4][5][6][7][8].
Cepharanthine
2alpha,4alpha,7beta,9alpha,1alpha,15-hexahydroxy-5alpha,20-diacetoxy-10beta-benzoxy-11(15->1)abeotaxa-11-ene|taxuyunnanine U
3beta,5alpha,8alpha,15beta-tetraacetoxy-7beta-propionyloxyjatropha-6(17),11E-diene-4,14-dione
6,12-dimethoxy-2,2-dimethyl-6,8alpha-(1-oxa-ethane-1,2-diyl)-8H-berbaman-7-one|Pseudorepandulin|pseudorepanduline
11,17-dimethoxy-18-(3,4,5-trimethoxy-benzoyloxy)-yohimb-19-ene-16-carboxylic acid methyl ester|11,17alpha-Dimethoxy-18beta-(3,4,5-trimethoxy-benzoyloxy)-3beta-yohimb-19-en-16beta-carbonsaeure-methylester|11,17alpha-dimethoxy-18beta-(3,4,5-trimethoxy-benzoyloxy)-3beta-yohimb-19-ene-16beta-carboxylic acid methyl ester|Raujemidin|Raujemidine.
(1R,2S,4S,5S,6R,7R,8S,9S,10S)-1,2-diacetoxy-9-benzoyloxy-15-(2-methylbutyroyloxy)-4,6,8-trihydroxydihydro-beta-agarofuran
Cys Ile Trp Trp
Cys Leu Trp Trp
Cys Trp Ile Trp
Cys Trp Leu Trp
Cys Trp Trp Ile
Cys Trp Trp Leu
Asp Met Arg Trp
Asp Met Trp Arg
Asp Arg Met Trp
Asp Arg Trp Met
Asp Trp Met Arg
Asp Trp Arg Met
His His Gln Trp
His His Trp Gln
His Gln His Trp
His Gln Trp His
His Trp His Gln
His Trp Gln His
Ile Cys Trp Trp
Ile Trp Cys Trp
Ile Trp Trp Cys
Leu Cys Trp Trp
Leu Trp Cys Trp
Leu Trp Trp Cys
Met Asp Arg Trp
Met Asp Trp Arg
Met Arg Asp Trp
Met Arg Trp Asp
Met Trp Asp Arg
Met Trp Arg Asp
Gln His His Trp
Gln His Trp His
Gln Trp His His
Arg Asp Met Trp
Arg Asp Trp Met
Arg Met Asp Trp
Arg Met Trp Asp
Arg Trp Asp Met
Arg Trp Met Asp
Val Tyr Tyr Tyr
Trp Cys Ile Trp
Trp Cys Leu Trp
Trp Cys Trp Ile
Trp Cys Trp Leu
Trp Asp Met Arg
Trp Asp Arg Met
Trp His His Gln
Trp His Gln His
Trp Ile Cys Trp
Trp Ile Trp Cys
Trp Leu Cys Trp
Trp Leu Trp Cys
Trp Met Asp Arg
Trp Met Arg Asp
Trp Gln His His
Trp Arg Asp Met
Trp Arg Met Asp
Trp Trp Cys Ile
Trp Trp Cys Leu
Trp Trp Ile Cys
Trp Trp Leu Cys
Tyr Val Tyr Tyr
Tyr Tyr Val Tyr
Tyr Tyr Tyr Val
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
(3s,3ar,4s,6s,7s,8s)-6-(acetyloxy)-4-(butanoyloxy)-3,3a-dihydroxy-3,6,9-trimethyl-8-{[(2z)-2-methylbut-2-enoyl]oxy}-2-oxo-4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-7-yl (2z)-2-methylbut-2-enoate
{[(4e,6z,8s,9s,10e,12s,13r,14s,16r)-3,13-dihydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-21-(methylsulfanyl)-20,22-dioxo-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18-hexaen-9-yl]oxy}methanimidic acid
{[13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-21-(methylsulfanyl)-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl]oxy}methanimidic acid
ajugacumbin e
{"Ingredient_id": "HBIN014965","Ingredient_name": "ajugacumbin e","Alias": "NA","Ingredient_formula": "C31H42O12","Ingredient_Smile": "CC1CC(C2(C(C1(C)CCC3=CC(=O)OC3)C(CC(C24CO4)OC(=O)C)OC(=O)C)COC(=O)C(=C)C(C)O)OC(=O)C","Ingredient_weight": "606.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14204","TCMID_id": "792","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "14781375","DrugBank_id": "NA"}